Replies to post #111461 on Bioelectronics Corp (BIEL)

[chado]

only thing that will not be another dead count bounce is SALES! and lots of SALES! (not a measly $2M globally).

agreement will move the pps for about 2 months before it's back in the trips due to our dilution battle wounds over the years.

Clearly, FDA alone won't sustain a pps move, as we are currently experiencing.

Keep in mind, AW has had 10 years to get agreements lined up...you'd think after FDA clearance it would be relatively quick. another slow-poke move by AW. Which tells me, their target partners aren't buying into the product. pretty simple.